Patent Term Application for FORZINITY (elamipretide), Patent No. 10,188,692 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-E-7116

Patent Term Application for FORZINITY (elamipretide), Patent No. 10,188,692

Documents

Comments

Key Dates

Comment Period OpensDec 18, 2025

Type	Title	Posted	Comments	Status
Other	Letter from FDA CDER to U.S. Patent and Trademark Office	Apr 20, 2026	--	--

CDER

Foley and Lardner LLP

Stealth BioTherapeutics Inc

Patent Term Application

for FORZINITY elamipretide

Patent No 10 188 692

OPEN